Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new public-private consortium (known as COMPACT) funded by the Innovative Medicines Initiative (IMI) of the EU recently launched a major new 30 million Euro project focussing on improving the delivery of biopharmaceutical drugs. The University of Oxford plays a leading
role in the consortium which also comprises experts from 14 academic institutions, two biotechnology companies and seven pharmaceutical companies. Professor Matthew Wood will lead all IMI work to develop improved methods for drug delivery to the brain. A major challenge in treating many currently incurable neurological diseases is to achieve effective drug delivery to the brain across the blood brain barrier (a natural barrier that protects the brain). This new IMI project aims to tackle this challenge within the next 5 years.

Similar stories

Randy Bruno named Academy of Medical Sciences Professor

Congratulations are in order for Professor Randy Bruno, who has been awarded an AMS Professorship. The AMS Professorship Scheme provides a package of support to biomedical and healthcare researchers taking up a full Professorship in the UK.

Nicola Smart appointed Associate Professor of Cellular and Integrative Physiology

The post is in association with a Tutorial Fellowship at Christ Church College.

REF 2021 results

Professor Irene Tracey CBE FMedSci nominated as next Oxford Vice-Chancellor

Congratulations are in order for Professor Irene Tracey, Warden of Merton College and former University Lecturer at DPAG, who has been nominated as the next Vice-Chancellor of the University of Oxford.

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.